Literature DB >> 29503325

Parkinson's disease: A review.

Divya M Radhakrishnan1, Vinay Goyal1.   

Abstract

Parkinson's disease is a common movement disorder seen in neurological practice, but the diagnosis and management is challenging. The diagnosis is clinical and sometimes difficult, considering a large number of motor and non-motor symptoms in PD patients. The medical management of PD patients is difficult, as choices of drugs are limited and levodopa is the mainstay of treatment. However, levodopa-induced dyskinesia (LID) is commonly seen in Parkinson's disease patients treated with levodopa. This side effect is usually encountered after a long duration of treatment, but occasionally, this may be seen even after a few days or months of treatment. Different types of surgical approaches, including unilateral pallidotomy and deep brain stimulation, have given very good results in PD patients, who cannot be managed by medications alone.

Entities:  

Keywords:  Deep brain stimulation; Parkinson's disease; dopaminergic drugs

Mesh:

Substances:

Year:  2018        PMID: 29503325     DOI: 10.4103/0028-3886.226451

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  15 in total

Review 1.  Glycolysis: The Next Big Breakthrough in Parkinson's Disease.

Authors:  Unaiza Naeem; Abdul Rehman Arshad; Areesha Jawed; Farea Eqbal; Laiba Imran; Zayeema Khan; Farhat Ijaz
Journal:  Neurotox Res       Date:  2022-09-24       Impact factor: 3.978

2.  Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment.

Authors:  Xiao-Xiao Fu; Jin Wang; Hua-Ying Cai; Hong Jiang; Jin-Zhan Jiang; Hao-Hao Chen; Shu Han
Journal:  J Inflamm Res       Date:  2022-07-07

Review 3.  Emerging role of S100B protein implication in Parkinson's disease pathogenesis.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

Review 4.  Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.

Authors:  Tapan Behl; Gagandeep Kaur; Ovidiu Fratila; Camelia Buhas; Claudia Teodora Judea-Pusta; Nicoleta Negrut; Cristiana Bustea; Simona Bungau
Journal:  Transl Neurodegener       Date:  2021-01-15       Impact factor: 8.014

5.  Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson's Disease via Activating the JAK2/STAT3 Pathway.

Authors:  ZhengHu Xu; Dongfeng Yang; Xiaojing Huang; Huai Huang
Journal:  Front Neurosci       Date:  2021-03-23       Impact factor: 4.677

6.  Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.

Authors:  Gagandeep Kaur; Tapan Behl; Simona Bungau; Arun Kumar; Md Sahab Uddin; Vineet Mehta; Gokhan Zengin; Bijo Mathew; Muhammad Ajmal Shah; Sandeep Arora
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

7.  Does parkinsonism affect periodontal health? A cross-sectional study in a tertiary hospital.

Authors:  Tony Kurien John; Beena Vasanthy; Baiju Radamoni Madhavanpillai; Mary Shimi Gomez; Rene Kuriakose
Journal:  J Indian Soc Periodontol       Date:  2021-11-01

Review 8.  Local Translation in Nervous System Pathologies.

Authors:  María Gamarra; Aida de la Cruz; Maite Blanco-Urrejola; Jimena Baleriola
Journal:  Front Integr Neurosci       Date:  2021-06-29

Review 9.  Recent Progress in Non-motor Features of Parkinson's Disease with a Focus on Circadian Rhythm Dysregulation.

Authors:  Yufei Liu; Long Niu; Xinyao Liu; Cheng Cheng; Weidong Le
Journal:  Neurosci Bull       Date:  2021-06-15       Impact factor: 5.271

Review 10.  Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions.

Authors:  Tapan Behl; Gagandeep Kaur; Simona Bungau; Rishabh Jhanji; Arun Kumar; Vineet Mehta; Gokhan Zengin; Roxana Brata; Syed Shams Ul Hassan; Ovidiu Fratila
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.